Patients suffering from chronic hives can enjoy more treatment options, as a new drug targeting the disease has been approved for registration in Hong Kong under the “1+” mechanism, the government said on Monday.
Under the mechanism, new drugs that are supported by local clinical data as well as recognised by local experts can apply to get registered in the city by submitting the approval from just one external drug regulatory authority…
阅读更多（Read More）